Cardiometabolic Disease Staging Predicts Effectiveness of Weight-Loss Therapy to Prevent Type 2 Diabetes: Pooled Results From Phase III Clinical Trials Assessing Phentermine/Topiramate Extended Release

OBJECTIVE: To assess the ability of medication-assisted weight loss to prevent diabetes as a function of the baseline weighted Cardiometabolic Disease Staging (CMDS) score. RESEARCH DESIGN AND METHODS: We pooled data from 3,040 overweight and obese participants in three randomized controlled trials—...

Descripción completa

Detalles Bibliográficos
Autores principales: Guo, Fangjian, Garvey, W. Timothy
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Diabetes Association 2017
Materias:
Clinical Care/Education/Nutrition/Psychosocial Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5481985/
https://www.ncbi.nlm.nih.gov/pubmed/28455281
http://dx.doi.org/10.2337/dc17-0088

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5481985/
https://www.ncbi.nlm.nih.gov/pubmed/28455281
http://dx.doi.org/10.2337/dc17-0088

Ejemplares similares